This one-day program at the Naomi Berrie Diabetes Center at Columbia University is designed for research scientists, clinicians and students with an interest in the molecular pathogenesis of type 1 diabetes and implications of these mechanisms for clinical interventions and, ultimately, prevention. As in the past, emphasis will be on the presentation of new and unpublished data, and on vigorous interactions between the audience and speakers.